← All diseases Cancer

Lung cancer (small cell)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (169)Meta-analysis (63)Treatment guideline (1)Randomized trial (47)Systematic review (35)Phase 3 study (23)Clinical trial (668)Review article (253)Early study (phase 1 or 2) (46)Case descriptions (157)Laboratory or animal research (71)Commentary or editorial (80)Retracted publication (17) Studies currently recruiting participants only (37)

Filter

Publications and studies (3263)

• [UPLC-Q-TOF-MS/MS-based guided isolation of phloroglucinols from Achyrocline satureioides and anti-lung cancer activity]. (2026/07/01) ♡
• Predictive Value of Peripheral Blood Inflammatory Markers and Nutritional Indices for Survival in Young Patients with Advanced Non-Small Cell Lung Cancer: Construction of a Nomogram. (2026/07/01) ♡
• Decoding Spectral Perturbations from a SERS Artificial Nose in Serum for Early Lung Cancer Detection. (2026/06/30) ♡
• Prognostic value of perioperative inflammatory biomarkers in patients undergoing surgical resection for non-small cell lung cancer. (2026/06/30) ♡
• A predictive model for immunotherapy in extensive-stage small cell lung cancer based on peripheral blood. (2026/06/30) ♡
• A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunction. (2026/06/29) ♡
• Deziyangxin suppresses non-small cell lung cancer through remodeling of the tumor immune microenvironment. (2026/06/28) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Heat-sensitive Moxibustion Enhances Immunity in Advanced Non-small Cell Lung Cancer via Th1/Th2 and Treg/Th17 Regulation. (2026/06/28) ♡
• Identification of unannotated microproteins involved in endothelial cell homeostasis, dysfunction, and vascular disease. (2026/06/26) ♡
• Body mass index and fasting insulin predict survival and EGFR-TKI benefit in Stage IV lung adenocarcinoma. (2026/06/25) ♡
• Prehabilitation in lung cancer patients undergoing lung resection surgery (Fit4LungNeo): study protocol. (2026/06/19) ♡
• Dual Mechanisms Underlie the Repression of Repressor Element 1-Silencing Transcription Factor Expression in Lung Neuroendocrine Carcinoma Cells. (2026/06/18) ♡
• Integrative Analysis of Glycosylation-Related Genes Reveals Prognostic Subtypes, Immune Evasion, and Therapeutic Vulnerabilities in Lung Adenocarcinoma. (2026/06/16) ♡
• Effect of hypoalbuminemia on postoperative pulmonary complications after thoracoscopic anatomical lung resection: a retrospective cohort study. (2026/06/11) ♡
• Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study. (2026/06/10) ♡
• Variability of the prognostic nutritional index within 3 months after curative resection for non-small cell lung cancer and 2-year recurrence-free survival. (2026/06/06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey. (2026/06/06) ♡
• Cost-Effectiveness Analysis of Anamorelin and Olanzapine for Cancer Cachexia in Non-Small Cell Lung Cancer Patients in Japan. (2026/06/04) ♡
• Comparison of PNI and GNRI nomogram models for predicting postoperative complications in elderly patients with lung cancer: a retrospective study. (2026/06/04) ♡
• Associations between early loss of skeletal muscle and osimertinib trough concentrations in patients with advanced EGFR-mutated NSCLC. (2026/06/03) ♡
• Zi Shen decoction inhibits non-small cell lung cancer progression by regulating macrophage polarization via the gut microbiota. (2026/06/02) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Submucosal-Predominant (Inverted-Type) Pyloric Gland Adenoma of the Duodenum Mimicking Malignancy. (2026/06/02) ♡
• Assessment of Circulating Cell Free DNA Methylation Biomarker of Panel of Selected Genes for Lung Cancer Detection. (2026/06/01) ♡
• Circular RNA ribosomal protein L15 accelerates epithelial mesenchymal transformation and tumour growth in non-small cell lung carcinoma via modulating the microRNA-518c-3p/WD repeat protein 1 axis. (2026/06/01) ♡
• Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axis. (2026/06/01) ♡
• Sijunzi Decoction Reverses Metabolic Adaptation and Induces Ferroptosis in Cisplatin-Resistant Non-small Cell Lung Cancer: An Integrative Metabolomics-Pharmacology Analysis. (2026/06/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Evaluating eight smoking metrics for modelling survival in non-small cell lung cancer. (2026/06/01) ♡
• Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. (2026/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Perioperative Considerations of Neoadjuvant and Perioperative Chemoimmunotherapy for Resectable Lung Cancer. (2026/05/29) ♡
• Prognostic impact of baseline blood biomarkers in SCLC first-line treatment. (2026/05/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Above and beyond BMI: Deciphering the lung cancer paradox]. (2026/05/21) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Association between the prognostic nutritional index and prognosis in patients with non-small cell lung cancer undergoing curative lung resection: a systematic review and meta-analysis. (2026/05/21) ♡
• Prognostic value of emotional distress in advanced non-small cell lung cancer: a systematic review and meta-analysis. (2026/05/20) ♡
• Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study. (2026/05/20) ♡
• Huayu Wan enhances immune checkpoint inhibitor efficacy in triple-negative breast cancer by normalizing tumor vasculature and remodeling the tumor immune microenvironment. (2026/05/19) ♡
• Glutamine Starvation Induces Ferroptosis in NSCLC via AMPK/PDZD8-Mediated Ferritinophagy. (2026/05/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pathogenesis and novel therapeutic perspectives in non-small cell lung cancer: Focusing on PI3K/AKT pathway regulation by traditional Chinese medicine monomers. (2026/05/15) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Preoperative Lactate Dehydrogenase-to-Albumin Ratio as a Tumor-Host Biomarker of Early Recurrence and Survival in Resected Pulmonary Neuroendocrine Carcinomas: A Multicenter Observational Cohort Study. (2026/05/13) ♡
• Exploring the prognostic value of the magnesium-immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving Nivolumab. (2026/05/01) ♡
• Particulate matter exposure negatively affects the cancer immunosurveillance through PD-L1 upregulation and dendritic cell maturation suppression. (2026/05/01) ♡
• Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors. (2026/05/01) ♡
• Isoliquiritigenin combined with gemcitabine inhibited lung cancer by suppressing JAK2/STAT3 signaling via lncRNA-p21/miRNA-4534 axis. (2026/05/01) ♡
• Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway. (2026/05/01) ♡
• Pneumonitis risk from pembrolizumab in non-small cell lung cancer: Interstitial abnormalities matter, and so does treatment. (2026/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Metabolic and cardiovascular disorders with lorlatinib: How to detect and manage them in practice?]. (2026/05/01) ♡
• Brief Report: A Pilot Study Evaluating the Feasibility, Safety, and Compliance With a Fasting-Mimicking Diet in Patients With Metastatic Non-Small Cell Lung Cancer. (2026/05/01) ♡
• Oncologic outcomes after declining lung cancer surgery: mixed methods analysis of a prospective pilot cohort. (2026/04/30) ♡
• Association between planetary health diet index and lung cancer risk in 106,542 participants: a prospective cohort study. (2026/04/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Interplay of Preoperative Sarcopenia, Systemic Inflammation, and Neoadjuvant Therapy in Resectable NSCLC-Identifying the Gap: A Narrative Review of Surgical and Oncological Outcomes. (2026/04/29) ♡
• Pretreatment Lactate Dehydrogenase-to-Albumin Ratio and Clinical Outcomes in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study. (2026/04/28) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.